Drug Shortage Report for PRO-ALPRAZOLAM
| Report ID | 120663 |
| Drug Identification Number | 01908170 |
| Brand name | ALPRAZOLAM-0.5 |
| Common or Proper name | ALPRAZOLAM |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | ALPRAZOLAM |
| Strength(s) | .5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1000 |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-07-20 |
| Estimated end date | 2020-08-18 |
| Actual end date | 2020-08-05 |
| Shortage status | Resolved |
| Updated date | 2020-08-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-08-06 | English | Compare |
| v5 | 2020-08-05 | French | Compare |
| v4 | 2020-08-05 | English | Compare |
| v3 | 2020-07-21 | English | Compare |
| v2 | 2020-07-20 | French | Compare |
| v1 | 2020-07-20 | English | Compare |
Showing 1 to 6 of 6